Recruiting studies: Narcolepsy Type 1 Nt1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
Phase 2 · 18 location(s) · Takeda · NCT07633301 A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central
Phase 2/Phase 3 · 7 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07598708 A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 2 · 24 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07096674 A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Phase 2 · 57 location(s) · Eisai Inc. · NCT07493265 A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Phase 3 · 22 location(s) · Alkermes, Inc. · NCT07455383 A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Phase 2/Phase 3 · 46 location(s) · Alkermes, Inc. · NCT06767683 Extended-release Sodium Oxybate in Children
Phase 2 · 1 location(s) · Stanford University · NCT06809803 A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1
Phase 3 · 10 location(s) · Alkermes, Inc. · NCT07540897 A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia
NA · 1 location(s) · University of Sydney · NCT07006233 A Phase 1, First-in-human Study of VX-433
Phase 1 · 1 location(s) · Vertex Pharmaceuticals Incorporated · NCT07584434 A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
Phase 3 · 25 location(s) · Takeda · NCT07363720

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.